BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 85477)

  • 1. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen.
    Elias EG; Chretien PB; Monnard E; Khan T; Bouchelle WH; Wiernik PH; Lipson SD; Hande KR; Zentai T
    Cancer; 1979 Mar; 43(3):1025-31. PubMed ID: 85477
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck.
    Rades D; Kronemann S; Meyners T; Bohlen G; Tribius S; Kazic N; Schroeder U; Hakim SG; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1037-44. PubMed ID: 20638185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of squamous cell carcinoma of the head and neck with methotrexate and irradiation.
    Friedman M; Daly JF
    Am J Roentgenol Radium Ther Nucl Med; 1967 Feb; 99(2):289-301. PubMed ID: 6020797
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck.
    Donegan WL; Harris HS
    Am J Surg; 1972 May; 123(5):549-59. PubMed ID: 4112554
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".
    Capizzi RL; DeConti RC; Marsh JC; Bertino JR
    Cancer Res; 1970 Jun; 30(6):1782-8. PubMed ID: 4248129
    [No Abstract]   [Full Text] [Related]  

  • 6. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Perry DJ; Weltz MD; Brown AW; Henderson RL; Neglia WJ; Berenberg JL
    Cancer; 1982 Dec; 50(11):2257-60. PubMed ID: 6182971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
    Mitchell MS; Wawro NW; DeConti RC; Kaplan SR; Papac R; Bertino JR
    Cancer Res; 1968 Jun; 28(6):1088-94. PubMed ID: 4298056
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx. (Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group).
    Kramer S
    Can J Otolaryngol; 1975; 4(2):213-8. PubMed ID: 1139418
    [No Abstract]   [Full Text] [Related]  

  • 9. Triple drug intra-arterial infusion combined with x-ray therapy and surgery for head and neck cancer.
    Cruz AB; McInnis WD; Aust JB
    Am J Surg; 1974 Oct; 128(4):573-9. PubMed ID: 4421747
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of carcinoma of the head and neck with intravenous methotrexate.
    Leone LA; Albala MM; Rege VB
    Cancer; 1968 May; 21(5):828-37. PubMed ID: 4172047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of 2 chemotherapy induction protocols. Cisplatinum-methotrexate-bleomycin and oncovin-methotrexate-bleomycin].
    Laccourreye H; Beutter P; Brasnu D; Lacau-Saint-Guily J; Bassot V; Garabedian N; Jacquillat C
    Ann Otolaryngol Chir Cervicofac; 1983; 100(4):269-74. PubMed ID: 6192747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Raafat J; Oster MW
    Cancer Treat Rep; 1980 Jan; 64(1):187-9. PubMed ID: 6155209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in advanced head and neck cancer. An update.
    Spaulding MB; Kahn A; De Los Santos R; Klotch D; Loré JM
    Am J Surg; 1982 Oct; 144(4):432-6. PubMed ID: 6181700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of epidermoid carcinoma of the oro-pharyngo-laryngeal area with combination of methotrexate and bleomycin].
    Broquet MA; Jacot-Descombe E; Montandon A; Alberto P
    Schweiz Med Wochenschr; 1974 Jan; 104(1):18-22. PubMed ID: 4128917
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx.
    Fazekas JT; Sommer C; Kramer S
    Int J Radiat Oncol Biol Phys; 1980 May; 6(5):533-41. PubMed ID: 7410127
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined therapy in advanced head and neck cancer: a randomized study.
    Gollin FF; Ansfield FJ; Brandenburg JH; Ramirez G; Vermund H
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):83-8. PubMed ID: 4550551
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment with chemotherapy in patients with advanced head and neck cancer.
    Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J
    J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
    Numico G; Russi EG; Vitiello R; Sorrentino R; Colantonio I; Cipolat M; Taglianti RV; Pelissero A; Fea E; Granetto C; Di Costanzo G; Gasco M; Garrone O; Occelli M; Merlano M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):731-7. PubMed ID: 17011449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
    Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
    Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.